Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036
Chan, Wayne W., Wise, Scott C., Kaufman, Michael D., Ahn, Yu Mi, Ensinger, Carol L., Haack, Torsten, Hood, Molly M., Jones, Jennifer, Lord, John W., Lu, Wei Ping, Miller, David, Patt, William C., Smith, Bryan D., Petillo, Peter A., Rutkoski, Thomas J., Telikepalli, Hanumaiah, Vogeti, Lakshminarayana, Yao, Tony, Chun, Lawrence, Clark, Robin, Evangelista, Peter, Gavrilescu, L. Cristina, Lazarides, Katherine, Zaleskas, Virginia M., Stewart, Lance J., Van Etten, Richard A., Flynn, Daniel L.
Published in Cancer cell (12.04.2011)
Published in Cancer cell (12.04.2011)
Get full text
Journal Article
Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region
Ahn, Yu Mi, Clare, Michael, Ensinger, Carol L., Hood, Molly M., Lord, John W., Lu, Wei-Ping, Miller, David F., Patt, William C., Smith, Bryan D., Vogeti, Lakshminarayana, Kaufman, Michael D., Petillo, Peter A., Wise, Scott C., Abendroth, Jan, Chun, Lawrence, Clark, Robin, Feese, Michael, Kim, Hidong, Stewart, Lance, Flynn, Daniel L.
Published in Bioorganic & medicinal chemistry letters (01.10.2010)
Published in Bioorganic & medicinal chemistry letters (01.10.2010)
Get full text
Journal Article